The U.S. government program that provides free at-home COVID tests is no longer accepting orders. The Administration for ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of ...

Reflects impairment of the goodwill and intangible assets recognized as a result of Illumina's acquisition of the Company in August 2021 ("the Acquisition"). Represents legal and professional ...

Sold More than 137,000 Galleri® Tests in 2024, Growing U.S. Galleri Revenue 45% Year-Over-Year to $108.6 Million Completed Study Visits for Two Registrational Studies ...

The Trump administration's quest to tame the sprawling federal bureaucratic ... more than a dozen states sought a temporary restraining order, accusing Elon Musk of "unconstitutional" actions.

Providers can now order the Galleri test directly from GRAIL through the Quest Diagnostics connectivity system ... “Risk Factors” in GRAIL’s most recent Quarterly Report on Form 10-Q filed with the ...

Providers can now order the Galleri test directly from GRAIL through the Quest Diagnostics connectivity system. The Quest Diagnostics connectivity system enables providers in the United States to ...

NEW YORK (Reuters) - The Justice Department's order to drop corruption charges against New York City Mayor Eric Adams will test whether a ... to Sassoon came in the form of a written memorandum ...

Providers can now order the Galleri test directly from GRAIL through the Quest Diagnostics connectivity ... GRAIL's most recent Quarterly Report on Form 10-Q filed with the SEC.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary ...